Skip to main content
. 2019 Apr 4;18:66. doi: 10.1186/s12934-019-1115-z

Fig. 5.

Fig. 5

CVB3-specific immune responses induced by oral administration of VP1 IBs. a CVB3-specific fecal IgA level. b CVB3-specific serum IgG level. c Frequency of IFN-ɣ producing cells in MLN. **P < 0.01; ***P < 0.001